Meet Monocl - Jens Wictorinus, VP of Engineering

VP of Engineering by day, professional sailor by weekend! Meet Jens Wictorinus!

Read more

The leading opinion leaders and rising stars in Hepatitis C

Your weekly stakeholder digest, this week with leading experts in Hepatitis C. In this post we outline the opinion leaders, rising stars and other key stakeholders as well as investigator and clinical trials trends.

Read more

Meet Monocl - Linda Zandi, Account Manager

Guess which Monocl Account Manager has a Harry Potter Tattoo!

Read more

GP Bullhound invests in Monocl

The funding will be used to expand Monocl’s US presence, including opening the US Headquarters in Boston, Massachusetts. The investment will also be used to grow and expand sales, marketing, customer success and product development teams in targeted markets.

Read more

Opinion leaders, rising stars and leading investigators in Age-Related Macular Degeneration

Your weekly stakeholder digest, this week with leading experts in AMD. In this post we outline the opinion leaders, rising stars and other key stakeholders as well as investigator and clinical trials trends.

Read more

When Should You Start KOL Engagement?

Most pharmaceutical companies start engaging KOLs during Phase 3 clinical trials. In our newest blog we look at why this makes sense and also discuss situations when bringing KOLs on board earlier during drug development might be the way to go.

Read more